| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/05/2005 | CN1559466A Traditional Chinese medicinal plaster |
| 01/05/2005 | CN1559465A Traditional Chinese herb medicine plaster for treating bone injury, and its prepn. method |
| 01/05/2005 | CN1559452A Navel applicaton powder medicine made of many kinds of herb medicines for treating rheumatoid diseases, and application method thereof |
| 01/05/2005 | CN1559401A Therapeutic use and compositions involving isoflavones |
| 01/05/2005 | CN1183157C Method for distillig active protein liquid of scorpion |
| 01/05/2005 | CN1183149C Pharmaceutical compositions containing oligosaccharides and preparation thereof |
| 01/05/2005 | CN1183148C Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium 2.5 hydrate or monohydrate |
| 01/05/2005 | CN1183147C Diphosphonic acid derivant and preparation process and application thereof |
| 01/05/2005 | CN1183136C Indoloquinazolinones |
| 01/05/2005 | CN1183133C 2-amino-6-anilino-purines and their use as medicaments |
| 01/05/2005 | CN1183122C Dipeptide nitrile cathepsin K inhibitors |
| 01/05/2005 | CN1183119C Arylpiperzines as metalloproteinase inhibiting agents (MMP) and their use |
| 01/05/2005 | CN1183107C Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 01/05/2005 | CN1182873C Arginine silicate inositol complex and use thereof |
| 01/05/2005 | CN1182866C Medicinal liquor for curing rheumatism and traumatic injuries |
| 01/05/2005 | CN1182844C Use of dialkylfumarates |
| 01/04/2005 | US6838584 Estrogen receptor modulators |
| 01/04/2005 | US6838559 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease |
| 01/04/2005 | US6838468 4-(phenyl-piperdin-4-ylidene methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 01/04/2005 | US6838466 Compounds for the treatment of inflammatory disorders |
| 01/04/2005 | US6838460 Substituted phenylamidines medicaments containing said compounds and method for production thereof |
| 01/04/2005 | US6838458 5-(alkylidene-cycloalkyl)-and 5-(alkylidene-heterocyclyl)-pyrazoles |
| 01/04/2005 | US6838456 Condensed pyridoindole derivatives |
| 01/04/2005 | US6838454 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 01/04/2005 | US6838453 Therapy for osteoporosis |
| 01/04/2005 | US6838444 Using nucleic acid; repair interior ear hair |
| 01/04/2005 | US6838439 Heterocytes as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 01/04/2005 | US6838433 Peptides used as inhibitors of interleukin-6 (IL-6), for prophylaxis, therapy and/or diagnosis of blood disorders such as leukemia |
| 01/04/2005 | US6838261 Nucleic acids encoding anti-CD40 proteins and methods of producing recombinant anti-CD40 proteins |
| 12/30/2004 | US20040267028 Such as 2-amino-1-(2-chlorophenyl)-5-(4-chlorophenyl)-N-cyclohexyl-1H-pyrrole-3-carboxamide hydrochloride |
| 12/30/2004 | US20040267016 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 12/30/2004 | US20040267012 5'-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 12/30/2004 | US20040266884 Compounds for blocking androgen receptors |
| 12/30/2004 | US20040266873 1-butane acid derivatives pharmaceutical compositions containing said derivatives and the use thereof |
| 12/30/2004 | US20040266870 Inhibitors of the chemotactic activation induced by the fraction C5a of complement and from other chemotactic proteins (chemokines) that y activate a 7-transmembrane-domain receptor; psoriasis, rheumatoid arthritis, ulcerative colitis, acute respiratory distress syndrome, fibrosis; antiischemic agents |
| 12/30/2004 | US20040266842 Thiazolyl substituted triazoles as alk5 inhibitors |
| 12/30/2004 | US20040266839 2'-Methyl-5-(1,3,4-oxadiazol-2-yl)1,1'-biphenyl-4-carboxaide derivatives and their use as p38 kinase inhibitors |
| 12/30/2004 | US20040266833 Novel use of certain insulin sensitizers or ppar-gamma agonists |
| 12/30/2004 | US20040266826 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors |
| 12/30/2004 | US20040266823 Such as N-[1-(3-phenyl-3-benzoylamino]propyl)-4-piperidinyl]-N-ethylmethanesulfonylphenylacetamide; autoimmune and inflammatory diseases; rheumatoid arthritis; synthesis |
| 12/30/2004 | US20040266805 Inflammation modulatory compound |
| 12/30/2004 | US20040266793 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders |
| 12/30/2004 | US20040266780 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 12/30/2004 | US20040266774 Amide compounds |
| 12/30/2004 | US20040266771 Use of tyrosine kinase inhibitors for treating bone loss |
| 12/30/2004 | US20040266770 treating diseases that are triggered by persistent angiogenesis; inhibition of the VEGF receptor |
| 12/30/2004 | US20040266764 Hydroxamic acid derivatives |
| 12/30/2004 | US20040266750 Beta-lactamyl vasopressin v1aantagonists |
| 12/30/2004 | US20040266742 Combination therapy of an sodm and a corticosteroid for prevention and/or treatment of inflammatory disease |
| 12/30/2004 | US20040266733 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1) |
| 12/30/2004 | US20040266676 Preventives/remedies for proliferative organ diseases chronic arthritic diseases. hypertrophic scar or keloid |
| 12/30/2004 | US20040265971 Cytokine for use in stem cell propagation and treatment ot cardiovascular, bone, nervous system and inflammatory disorders |
| 12/30/2004 | US20040265968 Tissue plasminogen activator-like protease |
| 12/30/2004 | US20040265927 Phospho-amino acid end groups interact with receptors on antigen-presenting cells; for treatment of T-cell mediated disorders (autoimmune conditions), inflammatory disorders, neurodegenerative disorders, and endothelial dysfunction disorders |
| 12/30/2004 | US20040265913 Tumor necrosis factors (TNF); humanized/chimeric monoclonal antibodies; fab fragments; hybridomas, host cells, Chinese Hamster Ovary cells |
| 12/30/2004 | US20040265837 As well as Paget's disease, neurological/neuromuscular diseases, nerve diseases, and/or psychotropic diseases; chloride channel modulators |
| 12/30/2004 | US20040265819 Uricosuric regulating action using protein comprising an amino acid sequence represented by SEQ ID NO:1 or an amino acid sequence derived therefrom being capable of transporting uric acid and its analogs; cardiovascular disorders; gout; hypotensive agents; nucleotide sequences; antibodies; modulators |
| 12/30/2004 | US20040265399 plant extracts used for prevention or treatment of lesions caused by estrogen deficiency |
| 12/30/2004 | US20040265382 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 12/30/2004 | US20040265350 Ceramic carrier comprising interconnected skeleton of scaffolding and struts having pores; low density; time-release agents; fibroblast-, or transforming growth factors; bone morphogenic proteins, somatotrophin; antibiotics, vitamins, proteins, hormones, radiopacity agents |
| 12/30/2004 | US20040265316 An antibody which specifically binds to a Fhit (fragile histidine triad) protein or derivative |
| 12/30/2004 | US20040265299 Comprising dextrin, starch, peach resin and magnesium stearate; use in hyperthyroidism therapy; reduce serum thyroid hormones level by binding thyroid hormones which is excreted to intestinal tract; hormone inhibitors |
| 12/30/2004 | US20040261190 Hydrazono-malonitriles |
| 12/29/2004 | WO2004113381A1 Relaxin superfamily peptide analogues |
| 12/29/2004 | WO2004113348A1 Thienopyridone derivatives as kinase inhibitors |
| 12/29/2004 | WO2004113310A1 Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing |
| 12/29/2004 | WO2004113303A1 INDAZOLE/PYRZOLO[4,3-c]PYRIDIN DERIVATIVES AS JNK INHIBITORS, COMPOSITIONS AND METHODS RELATED THERETO AS WELL AS INTERMEDIATE THEREOF |
| 12/29/2004 | WO2004113300A1 Novel tricyclic heterocycle compound |
| 12/29/2004 | WO2004112808A2 Therapeutic use of lipids extracted from mother of pearl |
| 12/29/2004 | WO2004098578A3 Composition comprising a pde4 inhibitor and a tnf-alfa antagonist selected from infliximab, adalimumab, cdp870 and cdp517 |
| 12/29/2004 | WO2004096828A3 Novel method and intermediates for the preparation of 19-nor-steroid compounds |
| 12/29/2004 | WO2003103671A8 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 12/29/2004 | WO2003082370A3 Transcellular drug delivery system |
| 12/29/2004 | WO2003045984A3 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 12/29/2004 | WO2003015797A8 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
| 12/29/2004 | WO2002043648A3 Compounds active at the glucocorticoid receptor ii |
| 12/29/2004 | WO2000061774A3 Bone morphogenic proteins |
| 12/29/2004 | EP1491556A1 Humanized immunoglobulins and their production and use |
| 12/29/2004 | EP1491551A1 Estrone derivative and process for producing the same |
| 12/29/2004 | EP1491537A1 Hydroxymorpholinone derivative and medicinal use thereof |
| 12/29/2004 | EP1491524A2 Selective androgen receptor modulators and methods of use thereof |
| 12/29/2004 | EP1491208A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 12/29/2004 | EP1491194A1 Vdac regulator |
| 12/29/2004 | EP1491192A1 Biological activity-promoting compositions containing soybean germ-origin isoflavone aglycon |
| 12/29/2004 | EP1491190A1 Decomposition inhibitor for extracellular matrix of cartilage |
| 12/29/2004 | EP1491093A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 12/29/2004 | EP1490406A1 Costimulatory molecule and its use |
| 12/29/2004 | EP1490405A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
| 12/29/2004 | EP1490404A1 Lactoferrin |
| 12/29/2004 | EP1490386A2 Novel polypeptides and nucleic acids encoding the same |
| 12/29/2004 | EP1490367A1 Imidazopyridine derivatives as kinase inhibitors |
| 12/29/2004 | EP1490366A1 Novel alkoxypyridine-derivatives |
| 12/29/2004 | EP1490365A1 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 12/29/2004 | EP1490364A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders |
| 12/29/2004 | EP1490356A1 (3z)-3-(3-hydro-isobenzofuran-1-ylidene)-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 12/29/2004 | EP1490354A1 4-imidazolyl substituted pyrimidine derivatives with cdk inhibitory activity |
| 12/29/2004 | EP1490352A1 Synthesis of piperidine and piperazine compounds as ccr5 antagonists |
| 12/29/2004 | EP1490343A1 New aryl imidazoles and related compounds as c5a receptor modulators |
| 12/29/2004 | EP1490341A1 Novel adamantane derivatives |
| 12/29/2004 | EP1490340A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain |